In anticipation of the FDA's tightening regulations on dietary supplements, Sabinsa Corporation validated the safety and quality of its key nutraceutical ingredients, and the conformance of its facilities to current good manufacturing practices.
Proof of product purity and safety was obtained by submitting these ingredients to NSF International, the well established public health and safety organization. Gugulipid® 40 mesh 2.5 percent extract, Curcumin C3 Complex®, Tribulus terrestris 20 percent extract, Indole-3-Carbinol and Triphala extract were some of the ingredients tested. Sabinsa's facilities were also audited by NSF for conformance to current good manufacturing practices.
As summarized by Todd Norton , President of Sabinsa Corporation:
"We felt it important to take a proactive stance and work directly with an independent third-party, and in cooperation with our customers, to ensure our ingredients comply to the highest industry safety standards."
The FDA published draft guidelines on the current good manufacturing practice requirements for dietary supplements in March 2003, and is currently reviewing comments from the industry. FDA is also working on introducing a regulatory strategy for dietary supplements with an increased emphasis on safety.
